These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11165410)

  • 1. Phase I study of paclitaxel (Taxol) plus vinorelbine (Navelbine) in patients with untreated stage IIIb and IV non-small cell lung cancer.
    Breton JL; Westeel V; Jacoulet P; Mercier M; Chazard M; Depierre A
    Lung Cancer; 2001; 31(2-3):295-301. PubMed ID: 11165410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer.
    Lorusso V; Crucitta E; Panza N; Silvestris N; Guida M; Carpagnano F; Mancarella S; Sambiasi D; De Lena M
    Ann Oncol; 2002 Dec; 13(12):1862-7. PubMed ID: 12453853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer.
    Clark JI; Kancharla K; Qamar R; Fisher S; Hantel A; Panganiban J; Millbrandt L; Albain KS
    Lung Cancer; 2001 Nov; 34(2):271-7. PubMed ID: 11679186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I/II trial of docetaxel and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy.
    Leu KM; Kim KM; Larson M; Larson M; Schiller JH
    Lung Cancer; 2001 Oct; 34(1):105-13. PubMed ID: 11557120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Front-line paclitaxel-vinorelbine versus paclitaxel-carboplatin in patients with advanced non-small-cell lung cancer: a randomized phase III trial.
    Stathopoulos GP; Veslemes M; Georgatou N; Antoniou D; Giamboudakis P; Katis K; Tsavdaridis D; Rigatos SK; Dimitroulis I; Bastani S; Loukides S; Vergos K; Marossis K; Grigoratou T; Kalatzi E; Charalambatou M; Paspalli A; Michalopoulou P; Stoka M; Gerogianni A
    Ann Oncol; 2004 Jul; 15(7):1048-55. PubMed ID: 15205198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I/II trial of paclitaxel and vinorelbine in advanced non-small cell lung cancer.
    Grunberg SM; Dugan MC; Greenblatt MS; Ospina DJ; Valentine JW
    Cancer Invest; 2005; 23(5):392-8. PubMed ID: 16193638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study of non-platinum based chemotherapy with paclitaxel and vinorelbine in non-small cell lung cancer.
    Ginopoulos P; Kontomanolis E; Kardamakis D; Sougleri M; Rathosis S; Karana A; Christias H; Mandellos G
    Lung Cancer; 2002 Nov; 38(2):199-203. PubMed ID: 12399133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboplatin and vinorelbine in untreated locally advanced and metastatic non-small cell lung cancer.
    Horvath L; Boyer M; Clarke S; Beale P; Beith J; Underhill C; Stockler M; Bishop J
    Lung Cancer; 2001 May; 32(2):173-8. PubMed ID: 11325488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancer.
    Bennouna J; Monnier A; Rivière A; Milleron B; Lemarie E; Trillet-Lenoir V; Soussan-Lazard K; Berille J; Douillard JY
    Eur J Cancer; 2000 Jun; 36(9):1107-12. PubMed ID: 10854943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbine.
    Kourousis C; Androulakis N; Kakolyris S; Souglakos J; Maltezakis G; Metaxaris G; Chalkiadakis G; Samonis G; Vlachonikolis J; Georgoulias V
    Cancer; 1998 Nov; 83(10):2083-90. PubMed ID: 9827712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinorelbine combined with paclitaxel infused over 96 hours (VI-TA-96) for patients with metastatic breast carcinoma.
    Cocconi G; Mambrini A; Quarta M; Vasini G; Bella MA; Ferrozzi F; Beretta MD
    Cancer; 2000 Jun; 88(12):2731-8. PubMed ID: 10870055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG).
    Kosmidis PA; Fountzilas G; Eleftheraki AG; Kalofonos HP; Pentheroudakis G; Skarlos D; Dimopoulos MA; Bafaloukos D; Pectasides D; Samantas E; Boukovinas J; Lambaki S; Katirtzoglou N; Bakogiannis C; Syrigos KN
    Ann Oncol; 2011 Apr; 22(4):827-834. PubMed ID: 20880999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I trial of docetaxel and vinorelbine in patients with advanced nonsmall cell lung carcinoma.
    Miller VA; Ng KK; Krug LM; Perez W; Pizzo B; Heelan RT; Kris MG
    Cancer; 2000 Mar; 88(5):1045-50. PubMed ID: 10699893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin plus continuous infusion vinorelbine for the treatment of advanced non-small cell lung cancer: a phase I-II study.
    Cobo-Dols M; Gil-Calle S; Villar-Chamorro E; Alés-Díaz I; Carabantes-Ocón F; Alcalde-García J; Gutiérrez-Calderón V; Montesa-Pino A; Bretón-García JJ; Benavides-Orgaz M
    Clin Transl Oncol; 2006 Jul; 8(7):519-24. PubMed ID: 16870542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vinorelbine and paclitaxel for locoregional advanced or metastatic non-small-cell lung cancer.
    Pérez JE; Machiavelli MR; Romero AO; Romero Acuña LA; Domínguez ME; Fasce H; Flores Acosta L; Marrone N; Romero Acuña JM; Langhi MJ; Amato S; Bologna F; Ortiz EH; Leone BA; Lacava JA; Vallejo CT
    Am J Clin Oncol; 2002 Aug; 25(4):383-7. PubMed ID: 12151970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral vinorelbine: pharmacology and treatment outcome in non-small cell bronchial carcinoma and breast carcinoma].
    Bartsch V
    Onkologie; 2006 Mar; 29 Suppl 1():1-28. PubMed ID: 16534241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I study of high-dose epirubicin and vinorelbine in previously untreated non-small-cell lung cancer stage IIIB-IV.
    Bakker M; Groen HJ; Smit EF; Smeets J; Riggi M; Postmus PE
    Br J Cancer; 1995 Dec; 72(6):1547-50. PubMed ID: 8519675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies.
    Hoffman PC; Masters GA; Drinkard LC; Krauss SA; Samuels BL; Golomb HM; Vokes EE
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):11-5. PubMed ID: 8677441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer.
    Tomonaga N; Nakamura Y; Soda H; Nagashima S; Nakano H; Kinoshita A; Fukuda M; Fukuda M; Takatani H; Soejima Y; Oka M; Kohno S;
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):43-9. PubMed ID: 17717667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.